Pharmacogenomics in Colorectal Cancer

E-ISSN： 1875-6204|5|2|117-123

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.2, 2007-06, pp. : 117-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

By Lentz Frederike Tran Agnès Rey Elisabeth Pons Gérard Tréluyer Jean-Marc

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

Research Highlights: Highlights from the latest articles in colorectal cancer pharmacogenomics

By Marsh Sharon

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 743-746

Future Medicine

Access to resources Recommend Favorite

Molecular Markers for Individualized Therapy in Colorectal Cancer: Progress Towards a Pharmacogenomics Array

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 1, 2009-03 ,pp. : 70-80

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics and stomach cancer

By Toffoli Giuseppe Cecchin Erika

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 627-641

Future Medicine

Access to resources Recommend Favorite